{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:25:26Z","timestamp":1792268726361,"version":"4.4.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jcf.2020.07.001","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T02:31:47Z","timestamp":1595557907000},"page":"278-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6088-6603","authenticated-orcid":false,"given":"Angela","family":"Garinis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Gleser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Johns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Vachhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcf.2020.07.001_bib0001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00003446-199912000-00005","article-title":"An individualized, sensitive frequency range for early detection of ototoxicity","volume":"20","author":"Fausti","year":"1999","journal-title":"Ear Hear"},{"key":"10.1016\/j.jcf.2020.07.001_bib0002","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/14992027.2010.524253","article-title":"Aminoglycoside antibiotics cochleotxicity in paediatric cystic fibrosis(CF) patients: a study using extended high-frequency audiometry and distortion product otoacoustic emissions","volume":"50","author":"Al-Malky","year":"2011","journal-title":"Int J Audiol"},{"issue":"3","key":"10.1016\/j.jcf.2020.07.001_bib0003","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jcf.2017.01.006","article-title":"The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis","volume":"16","author":"Garinis","year":"2017","journal-title":"J Cystic Fibros"},{"issue":"sup4","key":"10.1016\/j.jcf.2020.07.001_bib0004","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1080\/14992027.2018.1468092","article-title":"Vestibulotoxicity: strategies for clinical diagnosis and rehabilitation","volume":"57","author":"Handelsman","year":"2018","journal-title":"Int J Audiol"},{"key":"10.1016\/j.jcf.2020.07.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2020.107922","article-title":"EHF hearing and speech perception implications in adults and children","author":"Hunter","year":"2020","journal-title":"Hearing Res (in revision)"},{"issue":"6","key":"10.1016\/j.jcf.2020.07.001_bib0006","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7196\/SAMJ.4964","article-title":"Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients","volume":"102","author":"Harris","year":"2012","journal-title":"S Afr Med J"},{"issue":"4","key":"10.1016\/j.jcf.2020.07.001_bib0007","first-page":"905","article-title":"The incidence of amikacin ototoxicity in multidrug-resistant tuberculosis patients","volume":"10","author":"Javadi","year":"2011","journal-title":"Iran J Pharm Res"},{"issue":"159","key":"10.1016\/j.jcf.2020.07.001_bib0008","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/0194599818782444","article-title":"Progressive hearing loss among patients with cystic fibrosis and parenteral aminoglycoside treatment","author":"Zettner","year":"2018","journal-title":"Otolaryngol- Head Neck Surg"},{"issue":"57","key":"10.1016\/j.jcf.2020.07.001_bib0009","first-page":"917","article-title":"Negative hearing effects of a single course of IV aminoglycoside therapy in cystic fibrosis patients","author":"Gleser","year":"2018","journal-title":"Int J Audiol"},{"issue":"Suppl 12","key":"10.1016\/j.jcf.2020.07.001_bib0010","first-page":"11","article-title":"Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy","volume":"36","author":"Association","year":"1994","journal-title":"ASHA"},{"key":"10.1016\/j.jcf.2020.07.001_bib0011","unstructured":"Infection prevention and control clinical care guidelines. Available online:https:\/\/www.cff.org\/Care\/Clinical-Care-Guidelines\/Infection-Prevention-and-Control-Clinical-Care-Guidelines\/Infection-Prevention-and-Control-Clinical-Care-Guidelines\/."},{"issue":"2","key":"10.1016\/j.jcf.2020.07.001_bib0012","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s10162-002-2036-8","article-title":"Distribution of gentamicin in the guinea pig inner after local or systemic application","volume":"4","author":"Imamura","year":"2003","journal-title":"J Assoc Res Otolaryngol"},{"key":"10.1016\/j.jcf.2020.07.001_bib0013","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/00206098709081549","article-title":"Screening tympanometry: criteria for medical referral","volume":"26","author":"Margolis","year":"1987","journal-title":"Audiol: Br Soc Audiol, Int Soc Audiol Nordic Audiol Soc Stockholm"},{"issue":"Suppl","key":"10.1016\/j.jcf.2020.07.001_bib0014","first-page":"1","article-title":"Manual for program outline for rehabilitation of aural casualties both military and civilian","volume":"48","author":"Hughson","year":"1944","journal-title":"Trans Am Acad Ophthal Otolaryng"},{"issue":"7","key":"10.1016\/j.jcf.2020.07.001_bib0015","first-page":"493","article-title":"Uses and abuses of hearing loss classification","volume":"23","author":"Clark","year":"1981","journal-title":"ASHA"},{"issue":"3","key":"10.1016\/j.jcf.2020.07.001_bib0016","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jcf.2017.10.007","article-title":"Audiometric assessment of pediatric patients with cystic fibrosis","volume":"17","author":"Kreicher","year":"2018","journal-title":"J Cyst Fibrosis"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199320307931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199320307931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:42:43Z","timestamp":1761601363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199320307931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1569199320307931"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2020.07.001","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2020.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}